Metabolix PHA Deal

Metabolix (Cambridge, MA) says it signed a letter of intent with Antibioticos S.A. for the toll production of biobased polyhydroxyalkanoate (PHA) at Antiobioticos’ Leon, Spain facility. Production is expected to start in early 2013. The agreement comes six months after Archer Daniels Midland dissolved its PHA production joint venture with Metabolix and took ownership of the jv’s only...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers